Your browser is no longer supported. Please, upgrade your browser.
Settings
SNY Sanofi daily Stock Chart
SNY [NASD]
Sanofi
Index- P/E28.98 EPS (ttm)1.59 Insider Own16.40% Shs Outstand2.51B Perf Week2.71%
Market Cap116.12B Forward P/E12.99 EPS next Y3.55 Insider Trans0.00% Shs Float2.23B Perf Month2.78%
Income3.99B PEG3.76 EPS next Q0.96 Inst Own7.50% Short Float0.10% Perf Quarter9.46%
Sales40.89B P/S2.84 EPS this Y15.50% Inst Trans-0.20% Short Ratio1.55 Perf Half Y11.66%
Book/sh25.13 P/B1.84 EPS next Y8.49% ROA- Target Price52.00 Perf Year3.33%
Cash/sh2.98 P/C15.49 EPS next 5Y7.70% ROE- 52W Range40.00 - 47.11 Perf YTD6.36%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-2.00% Beta0.62
Dividend %3.77% Quick Ratio0.90 Sales past 5Y2.70% Gross Margin68.60% 52W Low15.42% ATR0.60
Employees104226 Current Ratio1.30 Sales Q/Q6.50% Oper. Margin- RSI (14)60.60 Volatility0.88% 1.08%
OptionableYes Debt/Eq0.47 EPS Q/Q-40.80% Profit Margin- Rel Volume0.76 Prev Close46.50
ShortableYes LT Debt/Eq0.39 EarningsOct 31 BMO Payout- Avg Volume1.46M Price46.17
Recom1.50 SMA201.23% SMA504.59% SMA2007.42% Volume1,112,244 Change-0.71%
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Nov-07-16Initiated Goldman Neutral
Oct-20-19 02:06PM  UPDATE 2-Star French banker Pigasse resigns from Lazard Reuters
Oct-18-19 11:21AM  Sanofi recalls Zantac because of possible contamination with potentially cancer-causing NDMA MarketWatch
11:06AM  Sanofi pulls Zantac from U.S. and Canada after carcinogen found Reuters
11:04AM  UPDATE 2-Sanofi pulls Zantac from U.S. and Canada after carcinogen found Reuters
11:00AM  Sanofi to pull heartburn drug Zantac in US, Canada Reuters
11:00AM  Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada PR Newswire
Oct-16-19 12:15PM  Novavax Begins Phase III Study on Influenza Vaccine Candidate Zacks
Oct-15-19 02:39PM  Sanofi opens new Framingham site amid $1.6B bet on bio-manufacturing American City Business Journals
12:21PM  AbbVie, Bristol-Myers Squibb Getting the Most From Workers GuruFocus.com
12:14PM  J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion Zacks
09:23AM  7 Value Price-to-Sales Stocks Poised to Fetch Strong Gains Zacks
09:10AM  Abbott Forms Alliance With Omada Health for Diabetes Care Zacks
08:00AM  Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing PR Newswire
Oct-13-19 05:15PM  New Sanofi CEO Looks to Shake Things Up GuruFocus.com
Oct-11-19 12:53PM  Emergent's Chikungunya Vaccine Candidate Gets EMA's PRIME Tag Zacks
Oct-10-19 09:57AM  Dermira Starts Lebrikizumab Dosing in Late-Stage Eczema Study Zacks
Oct-09-19 09:59PM  Hedge Funds Are In Wait And See Mode With Sanofi (SNY) Insider Monkey
11:15AM  J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case Zacks
Oct-08-19 10:31AM  Emergent's Vaccine Profile Boosts Sales Despite Stiff Rivalry Zacks
10:02AM  Verastem's (VSTM) Copiktra Gets Orphan Drug Designation Zacks
Oct-07-19 10:26AM  Wall Street Loves These Strong Buy Dividend Stocks TipRanks
Oct-03-19 07:18PM  Hagens Berman: Law Firm Taking on Drug Makers in Zantac Class Action Condemns FDAs Reckless Cover-up of Ranitidine Carcinogen Business Wire
Oct-02-19 03:29AM  Sanofi (EPA:SAN) Has A Pretty Healthy Balance Sheet Simply Wall St.
Oct-01-19 08:27AM  Sanofi to present strategy update in December-CEO Reuters
Sep-30-19 06:43PM  Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales Zacks
02:29PM  CVS suspends sales of Zantac during safety review Yahoo Finance Video
10:46AM  Pfizer's JAK1 Inhibitor Meets All Goals in 2nd Phase III Study Zacks
10:30AM  New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer PR Newswire
08:57AM  CVS pulls Zantac and its generic brand over possible cancer link CBS MoneyWatch
Sep-27-19 09:40AM  SNY or NVO: Which Is the Better Value Stock Right Now? Zacks
08:17AM  Buy These 3 Stocks With Upgraded Broker Ratings Right Now Zacks
Sep-26-19 12:38PM  Foreign Firms Recognized as Hottest Biotechs GuruFocus.com
12:09PM  Sanofi Canada receives Gold-Level Parity Certification CNW Group
11:59AM  Here's Why Sanofi (SNY) is Outperforming Its Industry Of Late Zacks
11:45AM  Here's Why AstraZeneca (AZN) is Outperforming Its Industry Zacks
08:01AM  After Shingles Standout, Glaxo Hunts for the Next Vaccines Bloomberg
Sep-25-19 06:22PM  Protalix Completes Enrollment in Third Fabry Disease Study Zacks
09:38AM  Moving Average Crossover Alert: Sanofi Zacks
09:10AM  Are Investors Undervaluing Sanofi (SNY) Right Now? Zacks
12:37AM  Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023 Moody's
Sep-24-19 04:32PM  Genzyme Corporation -- Moody's announces completion of a periodic review of ratings of Sanofi Moody's
11:46AM  Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023 Moody's
11:32AM  AstraZeneca Gets CHMP Nod for Forxiga/Onglyza Combo Tablet Zacks
Sep-23-19 12:08PM  Regeneron/Sanofi Gets Positive CHMP Opinion for Dupixent Zacks
10:54AM  Sanofi and Regeneron Stocks Will Gain Because Dupixent Collaboration is Big, Analysts Say Barrons.com
09:15AM  Sanofi (SNY) Soars to 52-Week High, Time to Cash Out? Zacks
Sep-20-19 05:42PM  Hagens Berman Files Second Class-Action Lawsuit Regarding Concealed Zantac Cancer Risk Business Wire
01:31PM  Stocks Reverse Lower On Trade Fears, But Small Caps Survive Investor's Business Daily
01:31PM  Stocks Reverse Lower On Trade Fears, But Small Caps Lose Less Investor's Business Daily
01:10PM  Carcinogen in Zantac Leads to Another Shipment Halt, Recall Bloomberg
10:51AM  Trovagene's Onvansertib Shows Response in Phase Ib AML Study Zacks
09:56AM  CGM Devices Gain Steam, Set New Trend in Diabetes Management Zacks
Sep-19-19 11:02AM  Alnylam Focuses on Pipeline Development Amid Competition Zacks
Sep-17-19 10:27AM  Alnylam Begins Phase III Study on Onpattro for New Indication Zacks
08:38AM  Abbott Partners With Sanofi to Upgrade Diabetes Management Zacks
03:42AM  Factbox: Britain's insulin providers prepare for Brexit fallout Reuters
01:00AM  Happify Health and Sanofi Sign Global Agreement to Bring Prescription Digital Mental Health Therapeutics to Individuals with Multiple Sclerosis PR Newswire
Sep-16-19 01:39PM  Top Trending: Abbott and Sanofi team up to help diabetes patients, Boeings board expected to reconsider engineering Yahoo Finance Video
01:18PM  Aimmune's Peanut Allergy Drug Gets FDA Committee's Support Zacks
09:13AM  Abbott, Sanofi to help diabetes patients with technology team-up Yahoo Finance
07:00AM  Market Morning: Johnson Defies Benn, Saudi Oil Black Swan, Golden Toilet Heist Market Exclusive
Sep-13-19 09:12PM  Hagens Berman: National Class-Action Lawsuit Accuses Sanofi of Concealing Zantac Cancer Risk Business Wire
04:16PM  Popular Sanofi Heartburn Drug Could Contain Carcinogens, FDA Says Investor's Business Daily
10:20AM  CORRECTED-U.S. FDA flags probable cancer-causing impurity in common heartburn drugs Reuters
10:08AM  Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use Zacks
09:01AM  FDA Says Sanofi's Zantac Medication Has Impurity That Could Cause Cancer TheStreet.com
06:28AM  NewsBreak: Low Levels of Carcinogen Found in Heartburn Drug Zantac Investing.com
Sep-12-19 09:41AM  J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients Zacks
Sep-11-19 07:42PM  Woodlands-based pharma co. to receive $260M in drug dispute settlement American City Business Journals
05:47PM  East Bay company eyes first drug approval after decade-long journey American City Business Journals
03:50PM  Leaner Pfizer Positioned to Boost R&D Output GuruFocus.com
09:46AM  Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally Zacks
07:09AM  The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway Benzinga
Sep-10-19 04:51PM  Sanofi to pay Lexicon $260 mln for terminated partnership Reuters
Sep-09-19 09:10AM  Should Value Investors Buy Sanofi (SNY) Stock? Zacks
Sep-06-19 09:14AM  UPDATE 1-Novo Nordisk to cut insulin prices in the U.S. Reuters
07:57AM  Novo Nordisk to cut insulin prices for some U.S. diabetics Reuters
Sep-05-19 12:52PM  Podcast: Why Big Pharma Is Betting on a New Biotech Therapy Barrons.com
11:12AM  Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class? Motley Fool
Sep-04-19 10:02AM  Biotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma & More Zacks
09:37AM  Novartis Inks Commercialization Deal for Tysabri Biosimilar Zacks
07:24AM  L'Oreal U.S.A. Inc. -- Moody's affirms L'Oréal S.A.'s Prime-1 rating, stable outlook Moody's
Sep-03-19 12:55PM  Here's How Emergent BioSolutions Procured a Higher Price Today Motley Fool
09:04AM  Sanofi Stock Is a Buy Because of Its Drug Pipeline, Analyst Says Barrons.com
03:11AM  What Kind Of Investor Owns Most Of Sanofi (EPA:SAN)? Simply Wall St.
Aug-30-19 10:26AM  Esperion's Bempedoic Acid Succeeds in Phase II Diabetes Study Zacks
08:04AM  Novartis' (NVS) MS Drug Achieves Goals in Late-Stage Studies Zacks
06:30AM  How To Trade Growth Stocks: The Easy Way To Check And Confirm Institutional Support Investor's Business Daily
02:17AM  UPDATE 2-Novartis takes aim at Roche's star MS drug Reuters
Aug-29-19 09:16AM  Regeneron-Sanofi Get Favorable Ruling Against Amgen in Court Zacks
07:38AM  The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings Benzinga
Aug-28-19 04:18PM  U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight Reuters
04:00PM  Biotech Stock On The Radar: MyoKardia Bets On Precision Medicine For Heart Health Benzinga
03:41PM  UPDATE 3-U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight Reuters
03:18PM  U.S. judge rules for Sanofi in Amgen patent fight Reuters
02:28PM  Emergent's Vaccine Portfolio Aids Growth Amid Competition Zacks
Aug-26-19 04:49PM  Inovio (INO) Down More Than 30% in 3 Months: Here's Why Zacks
11:05AM  Esperion's Drugs in Review Hold Potential, Funds a Concern Zacks
Aug-22-19 10:20AM  Pfizer's Xtandi Label Expansion Filing Gets Priority Review Zacks
09:10AM  Is Sanofi (SNY) a Great Value Stock Right Now? Zacks
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has an alliance with Verily Life Sciences LLC; and agreement with Happify Health. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerSep 10Sale281.15172,90448,611,80420,550,813Sep 12 05:00 PM
Sanofi10% OwnerJul 22Buy16.0093,7501,500,000558,035Jul 23 11:39 AM
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM